Cortexyme Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quince Therapeutics Inc (QNCX)
Track today's live Quince Therapeutics (QNCX) share price, performance and key data on this page with our current NASDAQ:QNCX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Quince Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the QNCX share price, head to our technical summary section, which provides analysis on Quince Therapeutics share price buy/sell indicators using real-time data (or discuss the Quince Therapeutics (QNCX) stock price today with other investors in the Quince Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:QNCX share price (ISIN: US22053A3059) to enhance your trading decisions with our free investment tools and resources.
What Is the Quince Therapeutics Inc Share Price Today?
The Quince Therapeutics share price today is 32.410.
What Is the Stock Symbol for Quince Therapeutics Inc
The stock symbol (or 'ticker') for Quince Therapeutics Inc is "QNCX."
What Stock Exchange Does Quince Therapeutics Inc Trade On?
Quince Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Quince Therapeutics Inc a Good Stock to Buy?
Determining whether Quince Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:QNCX share price (ISIN: US22053A3059) to enhance your trading decisions with our free investment tools and resources.
What Is the Quince Therapeutics Inc Share Price Today?
The Quince Therapeutics share price today is 32.410.
What Is the Stock Symbol for Quince Therapeutics Inc
The stock symbol (or 'ticker') for Quince Therapeutics Inc is "QNCX."
What Stock Exchange Does Quince Therapeutics Inc Trade On?
Quince Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Quince Therapeutics Inc a Good Stock to Buy?
Determining whether Quince Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
32.410
+0.260(+0.81%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.410
32.960
52 wk Range
3.660
909.980
QNCX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.41032.960
52 wk Range
3.660909.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QNCX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
77.200
Upside
+138.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K Quince Therapeutics Inc For: 14 August- Investing.com
Form PRE 14A Quince Therapeutics Inc For: 1 August- Investing.com
- Cortexyme Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Form 8K Quince Therapeutics Inc For: 17 August- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 77.200
(+138.20% Upside)
Earnings
Latest Release
14/08/2026
EPS / Forecast
-12.31 / -9.40
Revenue / Forecast
-- / --
Compare QNCX to Peers and Sector
Metrics to compare | QNCX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQNCXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.8x | −0.4x | |
PEG Ratio | 0.00 | −0.05 | 0.00 | |
Price/Book | −0.9x | 3.4x | 2.6x | |
Price / LTM Sales | - | 14.2x | 3.1x | |
Upside (Analyst Target) | 118.5% | 103.8% | 49.0% | |
Fair Value Upside | Unlock | 6.6% | 7.1% | Unlock |
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Quince Therapeutics (NASDAQ: QNCX) Share Price Today?
The Quince Therapeutics stock price today is 32.410 USD.
What Stock Exchange Does Quince Therapeutics (QNCX) Trade On?
Quince Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Quince Therapeutics?
The stock symbol (also called a 'ticker') for Quince Therapeutics is "QNCX."
What Is the Current Quince Therapeutics Market Capitalisation?
As of today, Quince Therapeutics (NASDAQ: QNCX) market cap is 32.960M USD.
What Is Quince Therapeutics's (QNCX) Earnings Per Share (TTM)?
The Quince Therapeutics EPS is currently -51.806 (Trailing Twelve Months).
When Is the Next Quince Therapeutics Earnings Date?
Quince Therapeutics's next earnings report will be released on 18/11/2026.
Is QNCX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Quince Therapeutics moving averages and other technical indicators, the daily buy/sell signal for QNCX stock is Neutral.
How Many Times Has Quince Therapeutics Stock Split?
Quince Therapeutics has split 2 times. (See the QNCX stock split history page for full effective split date and price information.)
How Many Employees Does Quince Therapeutics Have?
Quince Therapeutics has 38 employees, based on their latest Companies House report.
What is the current trading status of Quince Therapeutics (NASDAQ: QNCX)?
As of 03/09/2026, Quince Therapeutics (QNCX) is trading at a share price of 32.410 USD, with a previous close of 32.150 USD. The stock has fluctuated within a day range of 32.410 USD to 32.960 USD, while its 52-week range spans from 3.660 USD to 909.980 USD.
What Is Quince Therapeutics (QNCX) Price Target According to Analysts?
The average 12-month price target for Quince Therapeutics is 77.200 USD, with a high estimate of 98 USD and a low estimate of 68 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +138.20% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.